{{Rsnum
|rsid=7164883
|Gene=HCN4
|Chromosome=15
|position=73359833
|Orientation=plus
|GMAF=0.1882
|Gene_s=HCN4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 69.0 | 28.3 | 2.7
| HCB | 80.3 | 18.2 | 1.5
| JPT | 79.6 | 18.6 | 1.8
| YRI | 41.1 | 43.8 | 15.1
| ASW | 40.4 | 52.6 | 7.0
| CHB | 80.3 | 18.2 | 1.5
| CHD | 79.8 | 19.3 | 0.9
| GIH | 85.1 | 14.9 | 0.0
| LWK | 37.6 | 52.3 | 10.1
| MEX | 64.3 | 28.6 | 7.1
| MKK | 45.5 | 42.3 | 12.2
| TSI | 70.6 | 28.4 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22544366
|Trait=None
|Title=Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|RiskAllele=G
|Pval=3E-17
|OR=1.1900
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=25196315
|Title=The rs3807989 G/A Polymorphism in CAV1 is Associated with the Risk of Atrial Fibrillation in Chinese Han Populations
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}